Company Filing History:
3 out of 20 
2 out of 9 Years Active: 2016-2020
Title: Innovations by Tsu-I Catherine Wang in Oral Transmucosal Compositions
Introduction
Tsu-I Catherine Wang is an accomplished inventor based in Sugar Land, Texas. She has made significant contributions to the field of pharmaceutical compositions, particularly focusing on oral transmucosal delivery systems. With a total of five patents to her name, her work addresses critical health issues, including testosterone deficiency in men.
Latest Patents
Wang's latest patents include formulations for oral transmucosal compositions that incorporate aromatase inhibitors (AIs) aimed at treating low testosterone levels in men. These compositions are designed for both immediate and slow release, allowing for effective administration to increase testosterone levels in the bloodstream. The disclosed formulations can take various forms, including liquid and solid dosage forms, as well as chewing gums. Additionally, they may include mucoadhesive thin strips, films, tablets, patches, and tapes, among others. The innovative aspect of these compositions is their ability to deliver AIs directly into the patient's bloodstream, enhancing bioavailability and potentially reducing the required dosage.
Another notable patent involves oral transmucosal pharmaceutical compositions that combine low doses of testosterone with an aromatase inhibitor. This synergistic approach, combined with transmucosal absorption enhancers, allows for effective treatment of testosterone deficiency. Similar to her previous work, these compositions can be administered in various forms, ensuring high bioavailability and lower required doses.
Career Highlights
Throughout her career, Tsu-I Catherine Wang has worked with notable organizations, including Professional Compounding Centers of America. Her expertise in pharmaceutical formulations has positioned her as a key player in the development of innovative health solutions.
Collaborations
Wang has collaborated with professionals in her field, including Bruce Vincent Biundo, to further enhance her research and development efforts.
Conclusion
Tsu-I Catherine Wang's contributions to oral transmucosal compositions represent a significant advancement in the treatment of testosterone deficiency. Her innovative formulations not only improve the delivery of essential medications but also enhance patient outcomes. Wang's work continues to influence the pharmaceutical industry, paving the way for future innovations.